Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Listen to our new KP Research Radio episode and learn more about the risks and benefits of the PSA test to screen for prostate cancer.
Kaiser Permanente researchers showed starting annual colorectal cancer screening at age 45 in African Americans can find colorectal cancers at a rate similar to that seen when screening starts after age 50 — the age most guidelines currently recommend.
Kaiser Permanente Division of Research staff scientist Paola Gilsanz, ScD, is exploring the reasons for the unequal distribution of dementia risk among genders and ethnic groups.
Kaiser Permanente’s Northern California hospitals significantly increased minimally invasive surgery for hysterectomy and found the change also reduced racial disparities in the types of hysterectomies patients get.
Asian-Americans from different parts of Asia have very different cardiovascular risk factors and chronic conditions such as diabetes, hypertension, and heart disease, Kaiser Permanente research concludes.
The rate at which adults were diagnosed with attention deficit hyperactivity disorder doubled over ten years, increasing much faster than the diagnosis rate for children.
Alyce Adams, PhD, tackles 5 questions about the barriers to health care among vulnerable patient populations and her motivation towards finding solutions.
A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.
Compared with the non-Hispanic white (NHW) population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer, according to results published by Kaiser Permanente researchers and colleagues in Cancer Research, a journal of the American Association for Cancer Research.